Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on September 3, 2026

Sep. 3, 2026

Docter Advances Integrated Smart Aging-Care Platform for Community, Residential and Hospital Environments

Indeterminate EIN Presswire

Sep. 3, 2026

The End Brain Cancer Initiative Partners with Telix Pharmaceuticals for TLX101-Px (Pixclara®) and PDUFA Awareness

Indeterminate EIN Presswire

Sep. 3, 2026

Two Books, Two Gold Medals: Wellness Author Dr. Randall Hansen Honored in 2026 Readers' Favorite Awards

Indeterminate EIN Presswire

Sep. 3, 2026

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire

Sep. 3, 2026

New AI BioDesign accelerator combines experimental biology and artificial intelligence to learn nature’s design rules

Indeterminate EIN Presswire

Sep. 3, 2026

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire

Sep. 3, 2026

Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS

Indeterminate GlobeNewswire

Sep. 3, 2026

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

Indeterminate GlobeNewswire

Sep. 3, 2026

DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre

Indeterminate GlobeNewswire

Sep. 3, 2026

DBV Technologies to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Indeterminate GlobeNewswire

Sep. 3, 2026

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

New U.S. Treatment Recommendations Published for Severe Alopecia Areata in Adults

Indeterminate GlobeNewswire

Sep. 3, 2026

Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism

Indeterminate GlobeNewswire

Sep. 3, 2026

L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.

Indeterminate GlobeNewswire

Sep. 3, 2026

LB Pharmaceuticals to Participate in Upcoming September Investor Events

Indeterminate GlobeNewswire

Sep. 3, 2026

Agomab to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

CapsoVision to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire